Probiotic for Pancreatic β-Cell Function in Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
ConclusionsProbiotic therapies modestly improved β-cell function in patients with T2D. Modulating the gut microbiota represents a new diabetes treatment and should be tested in more extensive studies.Trial RegistrationNCT05765292.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: Clinical Trials | Diabetes | Endocrinology | Insulin | Oxford University | Pancreas | Probiotics | Study